🇺🇸 HBsAg in United States
23 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 23
Most-reported reactions
- Pain — 4 reports (17.39%)
- Dysphagia — 3 reports (13.04%)
- Adverse Event — 2 reports (8.7%)
- Arteriosclerosis Coronary Artery — 2 reports (8.7%)
- Arthropathy — 2 reports (8.7%)
- Asthma — 2 reports (8.7%)
- Back Pain — 2 reports (8.7%)
- Candida Infection — 2 reports (8.7%)
- Colorectal Adenoma — 2 reports (8.7%)
- Drug Intolerance — 2 reports (8.7%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is HBsAg approved in United States?
HBsAg does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for HBsAg in United States?
Vaxine Pty Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.